CBLL

CeriBell, Inc. is a medical technology company specializing in point-of-care diagnostic solutions for neurological conditions. The company has developed innovative technology for the rapid detection and monitoring of seizures, with a particular focus on neonatal and pediatric applications. CeriBell's flagship product is a portable, easy-to-use electroencephalography (EEG) system that enables clinicians to quickly assess brain activity and identify seizures at the patient's bedside. The company's technology addresses a critical gap in neurological care, where timely seizure detection can significantly impact patient outcomes and treatment decisions. CeriBell's solutions are designed to be used by healthcare providers without specialized training in traditional EEG interpretation, expanding access to neurological diagnostics. The company serves hospitals, neonatal intensive care units, and other healthcare facilities across the United States. CeriBell continues to invest in expanding its product portfolio and growing its commercial presence in the medical device market. The company operates in the rapidly evolving healthcare technology sector, where innovation and clinical validation drive market adoption.